Uncategorized
Biotech stocks are on a tear again
The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in April.
The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in April.